Gupta Kumkum, Sharma Deepak, Gupta Prashant K
Department of Anesthesiology & Crtical Care, N.S.C.B. Subharti Medical College, Subhartipuram, NH-58, Meerut, Uttarpradesh, India.
Saudi J Anaesth. 2011 Apr;5(2):179-84. doi: 10.4103/1658-354X.82791.
Hemodynamic responses of laryngoscopy and laparoscopy should be attenuated by the appropriate premedication, smooth induction, and rapid intubation. The present study evaluated the clinical efficacy of oral premedication with pregabalin or clonidine for hemodynamic stability during laryngoscopy and laparoscopic cholecystectomy.
A total of 180 healthy adult consented patients aged 35 to 52 years with American Society of Anesthesiologist (ASA) physical status I and II of both gender, who met the inclusion criteria for elective laparoscopic cholecystectomy, were randomized to receive placebo Group I, pregabalin (150 mg) Group II, or clonidine (200 μg) Group III, given 75 to 90 minutes before surgery as oral premedication. All groups were compared for preoperative sedation and anxiety level along with changes of heart rate and mean arterial pressure prior to premedication, before induction, after laryngoscopy, pneumoperitoneum, release of carbon dioxide, and extubation. Intraoperative analgesic drug requirement and any postoperative complications were also recorded.
Pregabalin and clonidine proved to have sedative and anxiolytic effects as oral premedicants and decreased the need of intraoperative analgesic drug requirement. Clonidine was superior to pregabalin for attenuation of the hemodynamic responses to laryngoscopy and laparoscopy, but it increased the incidence of intra-and postoperative bradycardia. No significant differences in the parameters of recovery were observed between the groups. None of the premedicated patient has suffered from any postoperative side effects.
Oral premedication with pregabalin 150 mg or clonidine 200 μg causes sedation and anxiolysis with hemodynamic stability during laryngoscopy and laparoscopic cholecystectomy, without prolongation of recovery time and side effects.
喉镜检查和腹腔镜检查的血流动力学反应应通过适当的术前用药、平稳诱导和快速插管来减轻。本研究评估了术前口服普瑞巴林或可乐定对喉镜检查和腹腔镜胆囊切除术期间血流动力学稳定性的临床疗效。
共有180名年龄在35至52岁之间、美国麻醉医师协会(ASA)身体状况为I级和II级的健康成年患者(男女均有),符合择期腹腔镜胆囊切除术的纳入标准,被随机分为三组:I组接受安慰剂,II组接受普瑞巴林(150毫克),III组接受可乐定(200微克),在手术前75至90分钟作为口服术前用药。比较所有组术前的镇静和焦虑水平,以及术前用药前、诱导前、喉镜检查后、气腹、二氧化碳释放后和拔管后的心率和平均动脉压变化。还记录了术中镇痛药的需求和任何术后并发症。
普瑞巴林和可乐定作为口服术前用药被证明具有镇静和抗焦虑作用,并减少了术中镇痛药的需求。可乐定在减轻喉镜检查和腹腔镜检查的血流动力学反应方面优于普瑞巴林,但增加了术中和术后心动过缓的发生率。各组之间在恢复参数方面未观察到显著差异。接受术前用药的患者均未出现任何术后副作用。
术前口服150毫克普瑞巴林或200微克可乐定在喉镜检查和腹腔镜胆囊切除术期间可引起镇静和抗焦虑作用,并具有血流动力学稳定性,且不延长恢复时间和无副作用。